Faculty Information - TABATA Tsutomu

（Last updated : 2022-03-24 10:57:09）

TABATA Tsutomu
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Obstetrics and Gynecology

Position Professor and Division head

■ Published papers

1.	Original article	Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study. 2022/03
2.	Case report	Clinicopathological characteristics and prognostic factors of ovarian granulosa cell tumors: A JSGO-JSOG joint study. 2021/11
3.	Original article	Prognostic Benefit of ≥6 Cycles of Neoadjuvant Chemotherapy for Advanced Ovarian, Tubal, and Peritoneal Cancers. 2021/08
4.	Original article	Immunochemical analysis of iron transporters and M2 macrophages in ovarian endometrioma and clear cell adenocarcinoma. 2021/06/11
5.	Original article	A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapy. 2021/04
6.	Original article	Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer. 2021/03
7.	Original article	The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. 2021/03
8.	Original article	Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. 2021/01
9.	Original article	Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry. 2021/01
10.	Original article	Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial. 2021/01
11.	Original article	The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG. 2020/11
12.	Case report	Fetal hepatomegaly might be a putative predictor for transient abnormal myelopoiesis with Down syndrome: a case report 2020/10/25
13.	Case report	Two primary cancers: Primary squamous cell carcinoma with extensive ichthyosis uteri and cervical endometrioid carcinoma: A case report. 2020/08/13
14.	Original article	Proposal of a Two-Tier System in Grouping Adenocarcinoma of the Uterine Cervix. 2020/05
15.	Original article	Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: A systematic review and meta-analysis. 2020/05
16.	Original article	Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group. 2020/04
17.	Original article	Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms. 2020/01
18.	Original article	Application of gamma-delta T cells obtained by ascites filtration for immunotherapy against malignant refractory ascites 2019/12/02
19.	Case report	Devolopment of severe thrombocytopenia 3 months after delivery complicated with early-onset preeclampsia: case report 2019/11/30
20.	Original article	Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer. 2019/11
21.	Review article	Ovarian cancer treatment by PARP inhibitor 2019/09
22.	Case report	A case of rapidly progressive glomerulonephritis due to anti-glomerular basement membrane antibody disease in pregnancy 2019/07
23.	Original article	Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study. 2019/06
24.	Original article	Evaluation of Cellular Adequacy in Endometrial Liquid-Based Cytology. 2019/05
25.	Case report	Safety and Efficacy of Laparoscopic Oophorocystectomy for Ovarian Dermoid Cyst Associated With Autoimmune Hemolytic Anemia 2018/02/16
Display 5 items
Display all(25)

■ Academic conference presentation

1.	Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) 50 mg/m2 and 40 mg/m2 in patients with platinum-resistant Müllerian carcinoma 2019/05
2.	The prognosis of patients with recurrent or persistent ovarian clear cell carcinoma: Results from a randomized phase III study 2019/05

■ Research areas

Obstetrics and gynecology

■ Education

Faculty of Medicine, Mie University, Graduated, Philosophiae　 Doctor